http://dbpedia.org/ontology/abstract
|
Ethinylestradiol sulfonate/norethisterone … Ethinylestradiol sulfonate/norethisterone acetate (EES/NETA), sold under the brand name Deposiston, is a combination medication of ethinylestradiol sulfonate (EES), an estrogen, and norethisterone acetate (NETA), a progestin, which was used as a combined birth control pill for women. It was formulated as oral tablets and contained 1 mg EES and 5 mg NETA per tablet. The medication had a long-lasting depot effect and was taken only once per week, for a total of four tablets per cycle. It was developed and marketed by Jenapharm and was previously available in Germany. EES/NETA was introduced for medical use in 1978.TA was introduced for medical use in 1978.
|
http://dbpedia.org/ontology/alternativeName
|
Deposiston
|
http://dbpedia.org/ontology/casNumber
|
54958-72-4
|
http://dbpedia.org/ontology/class
|
http://dbpedia.org/resource/Estrogen_%28medication%29 +
, http://dbpedia.org/resource/Progestogen +
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Ethinylestradiol_sulfonate.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
61227075
|
http://dbpedia.org/ontology/wikiPageLength
|
4442
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1011010848
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Norethisterone_acetate +
, http://dbpedia.org/resource/Ethinylestradiol_sulfonate +
, http://dbpedia.org/resource/Progestin +
, http://dbpedia.org/resource/Category:Combined_estrogen%E2%80%93progestogen_formulations +
, http://dbpedia.org/resource/Tablet_%28pharmacy%29 +
, http://dbpedia.org/resource/Combined_birth_control_pill +
, http://dbpedia.org/resource/Estrogen_%28medication%29 +
, http://dbpedia.org/resource/Progestogen +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/List_of_combined_sex-hormonal_preparations +
, http://dbpedia.org/resource/Jenapharm +
, http://dbpedia.org/resource/Germany +
, http://dbpedia.org/resource/Oral_administration +
, http://dbpedia.org/resource/Depot_effect +
, http://dbpedia.org/resource/Combination_drug +
|
http://dbpedia.org/property/caption
|
http://dbpedia.org/resource/Norethisterone_acetate +
, Ethinylestradiol sulfonate and
|
http://dbpedia.org/property/casNumber
|
54958
|
http://dbpedia.org/property/class
|
http://dbpedia.org/resource/Progestogen +
, http://dbpedia.org/resource/Estrogen_%28medication%29 +
|
http://dbpedia.org/property/component
|
Norethisterone acetate
, Ethinylestradiol sulfonate
|
http://dbpedia.org/property/drugName
|
norethisterone acetate
, Ethinylestradiol sulfonate /
|
http://dbpedia.org/property/image
|
Norethisterone acetate.svg
|
http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Oral_administration +
|
http://dbpedia.org/property/synonyms
|
EES/NETA
|
http://dbpedia.org/property/tradename
|
Deposiston
|
http://dbpedia.org/property/type
|
combo
|
http://dbpedia.org/property/width
|
250
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Progestogens_and_antiprogestogens +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Estrogens_and_antiestrogens +
, http://dbpedia.org/resource/Template:Progesterone_receptor_modulators +
, http://dbpedia.org/resource/Template:Genito-urinary-drug-stub +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Estrogen_receptor_modulators +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Combined_estrogen%E2%80%93progestogen_formulations +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Ethinylestradiol_sulfonate/norethisterone_acetate?oldid=1011010848&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Ethinylestradiol_sulfonate.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Norethisterone_acetate.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Ethinylestradiol_sulfonate/norethisterone_acetate +
|
http://xmlns.com/foaf/0.1/name
|
Ethinylestradiol sulfonate /
, norethisterone acetate
|
owl:sameAs |
https://global.dbpedia.org/id/AZfHj +
, http://www.wikidata.org/entity/Q65115155 +
, http://dbpedia.org/resource/Ethinylestradiol_sulfonate/norethisterone_acetate +
|
rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/CombinationDrug +
|
rdfs:comment |
Ethinylestradiol sulfonate/norethisterone … Ethinylestradiol sulfonate/norethisterone acetate (EES/NETA), sold under the brand name Deposiston, is a combination medication of ethinylestradiol sulfonate (EES), an estrogen, and norethisterone acetate (NETA), a progestin, which was used as a combined birth control pill for women. It was formulated as oral tablets and contained 1 mg EES and 5 mg NETA per tablet. The medication had a long-lasting depot effect and was taken only once per week, for a total of four tablets per cycle. It was developed and marketed by Jenapharm and was previously available in Germany. EES/NETA was introduced for medical use in 1978.TA was introduced for medical use in 1978.
|
rdfs:label |
Ethinylestradiol sulfonate/norethisterone acetate
|